FibroGen Inc is a San Francisco-based biopharmaceutical company focused on developing innovative therapies for serious and life-threatening diseases, including pancreatic cancer, prostate cancer, Duchenne muscular dystrophy, and anemia. With a strong emphasis on clinical trials and a commitment to responsible development, FibroGen is dedicated to bringing groundbreaking treatments to patients worldwide.
Through their subsidiary FibroGen China, the company is taking a unique approach to introducing world-class innovations in China. With a growing team of dedicated professionals, FibroGen is at the forefront of accelerating the development of novel therapies at the frontiers of cancer biology, aiming to positively impact and change lives.
Generated from the website